MHRA authorises in vivo genome editing trial
admin 1st March 2018 Uncategorised 0The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted permission for initiation of Europe’s first in vivo genome editing study.
More: MHRA authorises in vivo genome editing trial
Source: News